ask="1.80"
ask_size="3300"
average_daily_volume="43923"
bid="N/A"
bid_size="N/A"
book_value="0.81"
change="+0.01"
change_from_200_day_moving_average="0.03"
change_from_50_day_moving_average="-0.05"
change_from_52_week_high="-1.99"
change_From_52_week_low="0.47"
change_in_percent="+0.60%"
close="1.69"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.26"
ebitda="-6.98M"
eps_estimate_current_year="-0.16"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.48"
ex_dividend_date="N/A"
float_shares="2843000"
high="1.73"
high_52_weeks="3.68"
last_trade_date="3/9/2017"
last_trade_price="1.69"
last_trade_size="100"
last_trade_time="2:58pm"
low="1.62"
low_52_weeks="1.22"
market_capitalization="18.57M"
moving_average_200_day="1.66"
moving_average_50_day="1.74"
name="Cleveland BioLabs
Inc."
notes="N/A"
one_year_target_price="2.00"
open="1.71"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+1.87%"
percent_change_from_50_day_moving_average="-2.71%"
percent_change_from_52_week_high="-54.08%"
percent_change_from_52_week_low="+38.52%"
previous_close="1.68"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.07"
price_per_sales="4.86"
revenue="3.80M"
shares_outstanding="10987000"
short_ratio="0.11"
stock_exchange="NCM"
symbol="CBLI"
volume="14630"
weeks_range_52="1.22 - 3.68"
